JP2017000144A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017000144A5 JP2017000144A5 JP2016131637A JP2016131637A JP2017000144A5 JP 2017000144 A5 JP2017000144 A5 JP 2017000144A5 JP 2016131637 A JP2016131637 A JP 2016131637A JP 2016131637 A JP2016131637 A JP 2016131637A JP 2017000144 A5 JP2017000144 A5 JP 2017000144A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- fvii
- seq
- linker
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2010-0052719 | 2010-06-04 | ||
| KR20100052719 | 2010-06-04 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513120A Division JP6143297B2 (ja) | 2010-06-04 | 2011-06-07 | 第ｖｉｉ因子活性を有する融合タンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017000144A JP2017000144A (ja) | 2017-01-05 |
| JP2017000144A5 true JP2017000144A5 (enExample) | 2017-04-27 |
| JP6422918B2 JP6422918B2 (ja) | 2018-11-14 |
Family
ID=45067214
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513120A Expired - Fee Related JP6143297B2 (ja) | 2010-06-04 | 2011-06-07 | 第ｖｉｉ因子活性を有する融合タンパク質 |
| JP2016131637A Expired - Fee Related JP6422918B2 (ja) | 2010-06-04 | 2016-07-01 | 第ｖｉｉ因子活性を有する融合タンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513120A Expired - Fee Related JP6143297B2 (ja) | 2010-06-04 | 2011-06-07 | 第ｖｉｉ因子活性を有する融合タンパク質 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9644197B2 (enExample) |
| EP (1) | EP2576625B1 (enExample) |
| JP (2) | JP6143297B2 (enExample) |
| KR (1) | KR101331101B1 (enExample) |
| CN (2) | CN107188970A (enExample) |
| AU (1) | AU2011262494B2 (enExample) |
| BR (1) | BR112012030941A2 (enExample) |
| CA (1) | CA2801223C (enExample) |
| ES (1) | ES2676874T3 (enExample) |
| MX (1) | MX348567B (enExample) |
| RU (1) | RU2585231C2 (enExample) |
| WO (1) | WO2011152694A2 (enExample) |
| ZA (1) | ZA201300066B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9644197B2 (en) | 2010-06-04 | 2017-05-09 | Sk Chemicals Co., Ltd. | Fusion protein having factor VII activity |
| MX349054B (es) * | 2010-09-28 | 2017-07-07 | Aegerion Pharmaceuticals Inc | Leptinas altamente solubles. |
| US20140056870A1 (en) * | 2012-08-27 | 2014-02-27 | Allergan, Inc. | Fusion proteins |
| WO2014129876A1 (ko) | 2013-02-25 | 2014-08-28 | 에스케이케미칼주식회사 | 인자 vii을 포함하는 융합 단백질의 분리 및 정제 방법 |
| KR102058864B1 (ko) * | 2013-12-16 | 2019-12-24 | 주식회사 티움바이오 | 인자 vii의 융합 단백질을 포함하는 안정성이 개선된 약학적 조성물 |
| EP3351263A1 (en) | 2017-01-20 | 2018-07-25 | Universitätsklinikum Hamburg-Eppendorf | Pharmaceutical preparation for treating or preventing tissue adhesion |
| UA129696C2 (uk) | 2017-08-18 | 2025-07-09 | Ньютроліс Інк. | СКОНСТРУЙОВАНІ ФЕРМЕНТИ ДНКази ТА ЇХНЄ ЗАСТОСУВАННЯ В ТЕРАПІЇ |
| CN112996911A (zh) | 2018-10-08 | 2021-06-18 | 纽特雷斯股份有限公司 | 用于制造和疗法的脱氧核糖核酸酶的工程改造 |
| CN110218259B (zh) * | 2019-06-24 | 2022-09-16 | 王跃驹 | 植物生产胰高血糖素样肽-1短肽与转铁蛋白的融合蛋白制造口服降糖胶囊的应用 |
| CN110229237A (zh) * | 2019-06-24 | 2019-09-13 | 王跃驹 | 植物生产口服epo与转铁蛋白融合蛋白胶囊的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| WO2001058935A2 (en) | 2000-02-11 | 2001-08-16 | Maxygen Aps | FACTOR VII OR VIIa-LIKE MOLECULES |
| US7176278B2 (en) * | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
| CN1628126A (zh) * | 2001-08-30 | 2005-06-15 | 比奥雷克西斯药物公司 | 经修饰的运铁蛋白融合蛋白 |
| CN101177456A (zh) * | 2001-08-30 | 2008-05-14 | 比奥雷克西斯药物公司 | 经修饰的运铁蛋白融合蛋白 |
| US8129504B2 (en) | 2001-08-30 | 2012-03-06 | Biorexis Technology, Inc. | Oral delivery of modified transferrin fusion proteins |
| US7125843B2 (en) * | 2001-10-19 | 2006-10-24 | Neose Technologies, Inc. | Glycoconjugates including more than one peptide |
| CN100412090C (zh) * | 2002-05-01 | 2008-08-20 | 舍林股份公司 | 作为抗凝剂的新的靶向组织因子的血栓调节蛋白融合蛋白 |
| CN102268094A (zh) * | 2002-08-30 | 2011-12-07 | 比奥雷克西斯药物公司 | 被修饰的转铁蛋白抗体的融合蛋白 |
| US20070072271A1 (en) * | 2004-01-07 | 2007-03-29 | Novo Nordisk Healthcare A/G | Method for the production of recombinant proteins |
| EP1816201A1 (en) * | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
| TWI428448B (zh) * | 2006-03-24 | 2014-03-01 | Syntonix Pharmaceuticals Inc | 作為第九因子（ｆａｃｔｏｒ ｉｘ）原肽處理酶之ｐｃ５ |
| GB0614780D0 (en) * | 2006-07-25 | 2006-09-06 | Ucb Sa | Biological products |
| WO2009086132A2 (en) | 2007-12-20 | 2009-07-09 | University Of Southern California | Design of spacers to increase the expression of recombinant fusion proteins |
| CN105727261A (zh) | 2008-06-27 | 2016-07-06 | 杜克大学 | 包含弹性蛋白样肽的治疗剂 |
| CN102647945B (zh) * | 2009-12-08 | 2015-07-29 | 皇家飞利浦电子股份有限公司 | 用于校正示踪剂摄取测量结果的方法和校正系统 |
| US9644197B2 (en) | 2010-06-04 | 2017-05-09 | Sk Chemicals Co., Ltd. | Fusion protein having factor VII activity |
-
2011
- 2011-06-07 US US13/701,333 patent/US9644197B2/en not_active Expired - Fee Related
- 2011-06-07 JP JP2013513120A patent/JP6143297B2/ja not_active Expired - Fee Related
- 2011-06-07 AU AU2011262494A patent/AU2011262494B2/en active Active
- 2011-06-07 CA CA2801223A patent/CA2801223C/en active Active
- 2011-06-07 CN CN201710403215.1A patent/CN107188970A/zh active Pending
- 2011-06-07 EP EP11790052.2A patent/EP2576625B1/en active Active
- 2011-06-07 RU RU2012157301/10A patent/RU2585231C2/ru active
- 2011-06-07 KR KR1020110054573A patent/KR101331101B1/ko active Active
- 2011-06-07 CN CN2011800277076A patent/CN103068854A/zh active Pending
- 2011-06-07 ES ES11790052.2T patent/ES2676874T3/es active Active
- 2011-06-07 MX MX2012013807A patent/MX348567B/es active IP Right Grant
- 2011-06-07 WO PCT/KR2011/004131 patent/WO2011152694A2/en not_active Ceased
- 2011-06-07 BR BR112012030941A patent/BR112012030941A2/pt not_active Application Discontinuation
-
2013
- 2013-01-03 ZA ZA2013/00066A patent/ZA201300066B/en unknown
-
2016
- 2016-03-25 US US15/080,757 patent/US10696960B2/en active Active
- 2016-07-01 JP JP2016131637A patent/JP6422918B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012157301A (ru) | Слитый белок, обладающий активностью фактора vii | |
| HRP20200871T1 (hr) | Izmjenjeni rsv f proteini i postupci njihove uporabe | |
| JP2018537087A5 (enExample) | ||
| JP2018138049A5 (enExample) | ||
| HRP20240640T1 (hr) | Kimerni proteini faktora viii i njihova upotreba | |
| ES2629099T3 (es) | Derivados de serin proteasa y usos en la prevención o el tratamiento de y trastornos de la coagulación sanguinea | |
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| EA201101553A1 (ru) | Полипептид, деградирующий углеводы, и его применения | |
| SA522433360B1 (ar) | L-أَسْباراجيناز مُعدل | |
| JP2017018125A5 (enExample) | ||
| JP2012532601A5 (enExample) | ||
| JP2016505251A5 (enExample) | ||
| EA202190889A1 (ru) | Клостридиальные нейротоксины, содержащие экзогенную петлю активации | |
| JP2015212284A5 (enExample) | ||
| JP2012095652A5 (enExample) | ||
| EA201001881A1 (ru) | Пролинспецифичная протеаза из penicillium chrysogenum | |
| ATE471370T1 (de) | Varianten von beta-glukosidasen | |
| AR071874A1 (es) | Proteinas de dominio de armazon basadas en fibronectina multivalentes | |
| JP2015504052A5 (enExample) | ||
| JP2014509851A5 (enExample) | ||
| GB201201178D0 (en) | Novel enzymes | |
| BRPI0516176A (pt) | polipeptìdeo, dna, microorganismo, e, processo para produzir l-arginina, l-ornitina ou l-citrulina | |
| JP2018531624A5 (enExample) | ||
| JP2012512645A5 (enExample) | ||
| EA201300056A1 (ru) | Полипептид с активностью ацетилксиланэстеразы и его применения |